Category: Tweets Of The Week

Biotech Tweets of the Week (January 6, 2017)

1/6/2017

Just in time for the annual JP Morgan Healthcare conference & palooza, Biotech Tweets of the Week with @23aloha returns to BiotechDueDiligence. This edition features news, analysis, commentary, sentiment and discussion on the following top stories:

Alexion delayed the 10-Q this long for that? $ALXN
Halozyme pancreatic cancer data generates debate $HALO
Amgen wins unexpected PCSK9 legal ruling $AMGN $REGN $SNY
Ionis caps off flurry of news with another partnership $IONS $BIIB $NVS
"Who's zoomin' who?" [are companies giving investors the straight story?]
As seen on the stream - the best of the rest including $AEZS $AGN $ARNA $CLVS $ITEK $LOXO $NBIX $OGXI $OTIC $PIRS $XXII $XBI $IBB $LABU
And of course, anticiation and news leading up to #JPM17

Biotech Tweets of the Week (January 6, 2017 edition)

0 Comments

Biotech Tweets of the Week (December 5, 2016)

12/9/2016

0 Comments

Three big storylines dominated the discussion over the past week: #CuresNow, #ASH16, and #ForbesHealth. Catch up on these events and all the other top news and analysis in the Biotech Tweets of the Week curated by @23aloha and @BioDueDiligence, including:

21st Century Cures Act nears finish line #CuresNow
Amicus and Nivalis greet the week with setbacks $NVLS $FOLD
Arrowhead hits "Ctrl-Alt-Delete" on RNAi pipeine $ARWR
Inciteful conversations on trading biotech stocks, in light of so many bad news "blowups"
Drug pricing remains front and center at #ForbesHealth and elsewhere $MYL
Bluebird Bio warms up the crowd with pre-ASH myeloma data $BLUE
American Society of Hematology (#ASH16) Highlights

Continue on to Biotech Tweets of the Week (December 5, 2016)

0 Comments

Biotech Tweets of the Week (November 18, 2016)

11/27/2016

0 Comments

Highlights curated as always with @23aloha. This edition features:

Dynavax plunges on FDA rejection of HBV vaccine $DVAX
Corbus up on scleroderma proof of concept data, but question linger $CRBP
RNAi product for PCSK9 passes early test $MDCO $ALNY
Gilead's cold streak in the clinic continues $GILD $INCY
Another big shoe drops in Valeant - Philidor saga $VRX
As seen on the stream: best of the rest, including $ARWR $EXAS $OCUL $PBYI $PFE $QURE $TSRO $ZIOP $LABU $XBI $IBB #SITC2016 #FCP4C #AHA16

Continue on to the Biotech Tweets of the Week (November 14-18, 2016)

0 Comments

Biotech Tweets of the Week (November 4, 2016)

11/6/2016

0 Comments

It was a bit of a bleak week for the world of biotech, but plenty of story-lines for discussion and analysis. Catch up on all the action with the Biotech Tweets of the Week, curated by @23aloha and @BioDueDiligence.

0 Comments

Biotech Tweets of the Week (October 21, 2016)

10/23/2016

0 Comments

Not even the internet disruptions could hold us back this week. Enjoy the latest edition of the Biotech Tweets of the Week, curated with @23aloha. This edition features:

Celgene's long-awaited Crohn's disease data leaves questions $CELG
PTC hit with setback in attempt to ride Sarepta's coattails $PTCT $SRPT
Kite Pharma lays out its vision for the future at R&D Day $KITE
FDA and EMA regulators make waves on rare diseases, transparency $SRPT
$CRSP IPO completes the "CRISPR trifecta" $EDIT $NTLA
Puma "leads" latest round of biotech fundraising $PBYI $SNSS $NKTR
Third time is the charm for Alkermes depression drug $ALKS $CERC
As seen on the stream (the best of the rest including $ACAD $ALNY $ARIA $CRBP $DEPO $GILD $MDCO $PFE $PRQR $RIGL $SGMO $XBI $IBB

Read on: Biotech Tweets of the Week (October 16-21, 2016)

0 Comments

<<Previous

Biotech Tweets of the Week (January 6, 2017)

Biotech Tweets of the Week (December 5, 2016)

Biotech Tweets of the Week (November 18, 2016)

Biotech Tweets of the Week (November 4, 2016)

Biotech Tweets of the Week (October 21, 2016)

Categories

Archives